Source-Omega, a finished products manufacturer and educational marketing company, announced today their new peer-reviewed publication titled "A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food," written by Dr Scott D. Doughman, PhD, CEO and Chief Scientific Officer.
An internal Source-Omega report suggests at 3 months, high triglyceride reductions with DHA are temporally correlated with omega-3 essentiality, or saturation levels of omega-3s in red blood cell (RBC) membranes, also called the omega-3 index.
"What all the human omega-3 red blood cell data independently points out is that DHA is always 3 to 8 fold more abundant than EPA in human blood and tissues, even after prolonged intake of high doses of omega-3s predominantly as EPA," says company scientist.
Source-Omega's Pure One™ brand moves towards private label offering and licensing in a growing market with green economic outlook. Estimated at $400M, the total European omega-3 market is now doubling every 10 years.
Satisfied Users & 
Approved Press Releases
